卵巢癌P-糖蛋白、GST-π、P53、P185表达对近期化疗效果的影响
Expression of P-GP,GST-π,p53 and P185 in ovarian carcinomas and relationship with response to chemotherapy
-
摘要: 目的:评价卵巢癌P-糖蛋白、P53、P185表达对近期化疗效果的影响及相互关系。方法:免疫组织化学ABC法检测49例卵巢癌P-糖蛋白、GST－π、P53、P185表达。结果:1.卵巢癌P-糖蛋白、GST－π、P53、P185表达阳性者的近期化疗有效率分别为14.3％。27.3％、41、67％、24、63％,而表达阴性者的近期化疗有效率分别为53.6％(PAbstract: To evaluate the response to chemotherapy and relationship on expressionfo P-GP, GST-π, P53, P185in ovarian carcinomas.methods: lmmunohistochemical technique ABC was used to detect P-GP,GST-π,P53, P185content in 49 cases of ovarian carcinomas.results: 1.The response rates to chemotherapy of patients with positive stainingof P-GP, GST-π, P53, P185 were 14% 、27.3%、 41.7%、 24.3% respectively: but thoserates of patients with negative staining were 53.6% (P<0.005)、 56.3% (P<0.005)、48.2% (P<0.05)、 75.0% (P<0.005) respectively.2.There was a close correlation between expression of P-GP and P185 (P<0.05).conclusions: Expression of P GP,GST-π,P53and P185 affect the recent results of chemotherapy obviously in ovarian carcinomas.There was a researched value in depth on relationship between expression of P-GP and P185.
-
Key words:
- Ovarian neoplasm /
- p-glycoprotein /
- GST-π /
- P53 /
- P185 /
- immunohistochemistry
-
-
[1] Bradlay G, Juranka DF, Ling V. Machanism of multidrugresistance. Biochem. Biophys. Acta, 1988, 948:87 [2] Hamada S, Kamada M, Furumoto H, et al. Expression ofglutathion S-transferase-piin human ovarian cancer as anindictor of resistance to chemotherapy. Gynecol Oncol, 1994,52:313 [3] Tsai CM,Chang KT, Pemg RP, et s1,Correlation of in-trinsic chemresistance of non-small-cell cancer cell lineswith HER-2ineu gene expression but not with ras genemutatious. J NATI Cancer Inst,1988, 85:897 [4] Chin K. Ueda K,Pstan 1,et al. Modulation of activity ofthe promoter of the human MDRI gene by ras and 1353. Sci--ence, 1992,255:459 [5] 倪灿荣主编.免疫组织化学实验新技术及应用.北京科学技术出版社.p128 [6] Rubin SC,Finstad Cl,Hoskins WJ,et al. Expression ofP-glycoprotein of MDR, (P-glycoprotein) gene expres-sion in ovarian and small-cell lung carcinoma. J Natl Can-cer lnst, 1992, 84.1486 [7] Murphy D, Mc Crown AT, Hall A, et al. Clutathione S-transferase activity and isoenzyme distribution in ovariantumor biopsies taken before or after cytotoxic chemothera-py. Br J Cancer, 1992, 66:937 [8] Baekelandt M,Kristensen G, Holm R, et al. P-GP ex-pression as a possible marker for response to cisplatin/epirubicin as first line treatment in advanced ovarian can-cer. 1st international conferance on reversal of multidrugresistance in cancer: abstracts. Anticancer drug 1994, 5(suppl 1):59 [9] Felip E, Campo JMD, Rubio D, et al. C)verexpresston ofC-erbB/2 in eoithelial ovarian cancer-prognotic value andrelationship with response to chemotherapy. Cancer, 199575:2147
计量
- 文章访问数: 961
- HTML全文浏览量: 24
- PDF下载量: 232
下载:
